Table 2.

Best confirmed responses to ixa-dex and pom-dex in the ITT population.

Confirmed best response	Ixa-dex N = 73 n (%) [Exact 95% CI]	Pom-dex N = 49 n (%) [Exact 95% CI]	OR [95% CI]	P value
ORR (CR + PR + VGPR)	28 (38) [27–50]	20 (41) [27–56]	0.90 [0.43–1.90]	0.634
CR + VGPR	5 (7) [2–15]	8 (16) [7–30]	0.36 [0.11–1.20]	0.080
CR	0	2 (4) [<1–14]	NE	0.058
sCR	0	0
VGPR	5 (7) [2–15]	6 (12) [5–25]
PR	23 (32) [21–43]	12 (24) [13–39]
SD	33 (45) [34–57]	19 (39) [25–54]
PD	8 (11) [5–20]	5 (10) [3–22]

CI confidence interval, CR complete response, dex dexamethasone, ITT intent-to-treat, ixa ixazomib, NE not estimable, OR odds ratio, ORR overall response rate, PD progressive disease, pom pomalidomide, PR partial response, sCR stringent complete response, SD stable disease, VGPR very good partial response.